Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39033

DNAAF2 Knockout huh-7 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Liver

  • Disease:

    Hepatocellular carcinoma

The DNAAF2 Knockout Huh-7 Polyclonal Cells consist of a CRISPR/Cas9-edited polyclonal knockout population in Huh-7 human hepatocellular carcinoma cells, targeting DNAAF2, which is essential for axonemal dynein arm preassembly and ciliary motility. This loss-of-function model is intended for primary ciliary dyskinesia research, with DNAAF2 regulated by FOXJ1 and interacting with DNAAF1 and dynein chains. Applications include ciliogenesis assays, dynein subunit analysis, and cancer-related functional tests such as proliferation and migration assays. The Huh-7 background supports hepatic drug metabolism and HCV studies, providing a versatile tool for ciliary assembly research in a liver cancer context.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Huh-7

    Sex of Donor

    Male

    Age

    57 years

    Gene Name

    DNAAF2

    Gene Identifier

    NCBI Gene ID 55172

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAAF2 Knockout Huh-7 Polyclonal Cells product consists of a polyclonal population of Huh-7 human hepatocellular carcinoma cells engineered via CRISPR/Cas9-mediated gene disruption to introduce a loss-of-function modification in the DNAAF2 gene. This targeted gene knockout model enables the study of DNAAF2-dependent molecular mechanisms in a hepatic cellular environment without relying on single-cell clones, offering a heterogeneous yet genetically disrupted cell pool suitable for population-level functional assays.

Huh-7 is an epithelial cell line derived from a liver tumor of a 57-year-old Japanese male. This well-established model is widely utilized in hepatitis C virus replication studies and hepatic drug metabolism research due to its robust growth and relevance to liver cancer biology. The parental Huh-7 line retains key hepatocyte features and can be induced to undergo ciliogenesis under serum-deprived conditions, making it a suitable host for investigating genes involved in ciliary assembly and function.

DNAAF2 encodes a cytoplasmic co-chaperone that is essential for the preassembly of axonemal dynein arms, the molecular motors driving ciliary motility. DNAAF2 functions in concert with interacting factors such as DNAAF1, DNAAF3, and DNAAF4, and directly complexes with dynein heavy and intermediate chains to facilitate correct assembly of outer and inner dynein arms. Upstream, DNAAF2 expression is regulated by transcription factors FOXJ1, RFX2, and RFX3, which are master regulators of ciliogenesis. Downstream, DNAAF2 activity is required for dynein arm assembly and subsequent ciliary beat frequency, and its loss leads to immotile cilia. Within the broader pathway, DNAAF2 acts alongside DNAAF1, DNAAF3, dynein heavy chains, and axonemal docking complexes to ensure proper axonemal architecture and mucociliary clearance.

In the Huh-7 hepatocellular carcinoma background, this DNAAF2 knockout offers a unique tool to dissect ciliary assembly pathways in a liver-derived cell line. Although cilia are not typically prominent in hepatocytes, Huh-7 cells can be induced to form primary cilia, and disruptions in ciliary genes have been increasingly linked to cancer-related signaling, including proliferation and migration. This model therefore allows investigation of how DNAAF2 loss impacts cilia-dependent processes such as mucociliary clearance dysfunction and dynein arm assembly, as well as broader cellular phenotypes in a cancer-relevant context. It provides a relevant platform for primary ciliary dyskinesia modeling without relying on specialized respiratory cell lines.

This DNAAF2 knockout polyclonal cell population supports serum starvation-induced ciliogenesis assays with immunofluorescence detection of acetylated ??-tubulin, western blot analysis of dynein subunits, and RT-qPCR profiling of cilia-related genes. Functional assays including proliferation, migration, and cisplatin sensitivity testing extend its utility to cancer biology. Genetic interaction studies with partners such as DNAAF1 and DNAAF3 can delineate the dynein arm assembly pathway. For further technical details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)